Outcome Capital, a life sciences and healthcare advisory and investment banking firm, has appointed Peter Meyer as managing director in its Boston office.
Meyer will expand the firm’s medical device and life sciences services practices within Outcome’s platform, providing M&A, capital raising and advisory services to his clients. Prior to joining Outcome Capital, Meyer was vice president of strategy and corporate development at Vicarious Surgical, a developer of soft-tissue surgical robotics. He previously served as senior director of business development for Insulet Corporation, orchestrating investments in margin and portfolio expansion for this leading manufacturer of diabetes technology.